Home Insights

Insights

30 Oct 2026

KOL Strategy in Southeast Asia: Influence Is Not What Global Teams Think

Understand why pharma KOL strategies must adapt to local influence networks, healthcare systems and medical affairs realities across Southeast Asia.
30 Oct 2026

The Next Frontier: Digital and AI-Driven Pharma Commercial Models in Southeast Asia and ANZ

Explore how AI and digital transformation are reshaping pharmaceutical commercial strategies across Southeast Asia and ANZ, and the challenges of scaling.
30 Oct 2026

Winning (and Losing) in Government Tenders Across Southeast Asia

Discover the challenges of government pharmaceutical tenders in Southeast Asia, from pricing and procurement to regulatory readiness and execution.
30 Oct 2026

The Regional Leader’s Real Job: Why It Is Not Simply Managing Countries

Explore the real responsibilities of regional pharmaceutical leaders, from resource allocation to strategic decisions across Southeast Asia and ANZ.
30 Oct 2026

Why Global Pricing Strategies Break in Southeast Asia and ANZ

Explore why global pharmaceutical pricing strategies often fail in Southeast Asia and ANZ, and how local market realities shape pricing and access.